<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5090213 Figure_1-A</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>All analyses were performed using AhCre Eed+/+ and AhCre Eedfl/fl mice (n=5) injected with &#946;-naphthoflavone and sacrificed after 15 days. A) Immunohistochemistry analysis of small intestinal sections, using the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_1-B</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>All analyses were performed using AhCre Eed+/+ and AhCre Eedfl/fl mice (n=5) injected with &#946;-naphthoflavone and sacrificed after 15 days. B) Western blot analysis with protein extracts obtained from ex vivo-purified intestinal crypts and probed with the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_1-C</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>All analyses were performed using AhCre Eed+/+ and AhCre Eedfl/fl mice (n=5) injected with &#946;-naphthoflavone and sacrificed after 15 days. C) Haematoxylin and eosin staining of sections prepared from different intestinal tracts.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_1-D</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>All analyses were performed using AhCre Eed+/+ and AhCre Eedfl/fl mice (n=5) injected with &#946;-naphthoflavone and sacrificed after 15 days.  D) Immunohistochemistry analysis of small intestinal sections, using specific antibodies for the proliferation marker KI67.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_1-E</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>All analyses were performed using AhCre Eed+/+ and AhCre Eedfl/fl mice (n=5) injected with &#946;-naphthoflavone and sacrificed after 15 days. E) Expression analysis by qRT-PCR of the proliferation related markers indicated in the figure using RNA extracted from intestinal crypts. Graphs show mean &#177; SD for three replicates.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_2-A-B</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A) PAS and (B) Alcian blue staining of sections prepared from the different intestinal tracts isolated from AhCre Eed+/+ and AhCre Eedfl/fl mice (n=5) injected with &#946;-naphthoflavone and sacrificed after 15 days.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_2-C</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Quantification (mean &#177; SD) of Goblet cells in crypts and villi from the same mice sown in A and B. More than 100 crypts and villi were scored for each condition after 15 days from the first &#946;-naphthoflavone administration.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_2-D</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Immunohistochemistry analyses in AhCre Eed+/+ and AhCre Eedfl/fl mice injected with &#946;-naphthoflavone and sacrificed after 15 days using a lysozyme-specific antibody (upper panels: LYZ, a Paneth cell-specific marker). Histochemical assay probing for alkaline phosphatase activity is presented in the middle panels (ALPI, an enterocyte-specific marker). Combined Ki67 immunohistochemistry and histochemical Alcian blue staining is presented in the lower panels (Alcian/KI67).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_2-E</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) GFP expression from an Lgr5-eGFPtransgene identifying LGR5+ ISCs in near-native agarose-embedded sections from Eed+/+ and Eed-/- mice at 30 days from the first &#946;-naphthoflavone administration. Cell nuclei were counterstained with DAPI.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_3-A</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Radiation-induced intestinal regeneration: AhCre Eed+/+ and AhCre Eedfl/fl mice were injected with &#946;-naphthoflavone, irradiated with 10 Gy 15 days later, and sacrificed 4 and 8 days after irradiation. Sections prepared from the different intestinal tracts were stained with haematoxylin and eosin (n=6).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_3-B-C</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B) Immunohistochemistry analyses in AhCre Eed+/+ and AhCre Eedfl/fl mice treated as in A using H3K27me3 and KI67 specific antibodies at 8 days post-irradiation. C) Quantification (mean &#177; SD) of KI67 positive cells per crypt (B). More than 100 crypts were scored for each condition.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_3-D</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) In vitro organoids formation using crypts isolated from AhCre Eed+/+ and AhCre Eed-/- mice 15 days after the first &#946;-naphthoflavone injection. Organoids pictures were taken 5 days later at low and higher magnification (insets).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-A</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Volcano plot showing the expression changes with a minimal fold change of 3 (FC=3) at genome-wide levels in AhCre Eed-/- crypts relative to AhCre Eed+/+ crypts 15 days after &#946;-naphthoflavone administration.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-B</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Bar plot showing the percentage of H3K27me3-positive promoters among the differentially regulated genes in Eed-/- crypts. All gene promoters and 5 independent random sampling of 167 gene promoters extracted the mouse genome are presented as specificity controls.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-C</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Intensity profiles for H3K27me3 and SUZ12 occupancy at the promoters of up-regulated genes with respect to down-regulated genes in Eed-/- crypts.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-D</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Genomic snapshots of the Cdkn2a locus showing SUZ12 occupancy and H3K27me3 deposition at the promoter regions of both the p16 and the ARF isoforms.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-E</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) Genomic snapshots of the RNAseq profile of the Cdkn2a locus in AhCre Eed+/+ and AhCre Eed-/- crypts 15 days after &#946;-naphthoflavone administration.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-F</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F) Expression analysis by qRT-PCR (mean &#177; SD) of both Cdkn2a isoforms (p16Ink4A and p19Arf) in AhCre Eed+/+ and AhCre Eed-/- crypts 15 days after &#946;-naphthoflavone administration.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_4-G</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G) Gene set enrichment analysis (GSEA) using specific secretory and enterocytic transcriptional signatures with respect to the list of up-regulated genes in Eed-/- crypts.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_5-A</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Haematoxylin and eosin (top panels) and PAS staining (bottom panels) of sections prepared from different intestinal tracts in AhCre Cdkn2a-/- Eed+/+ and AhCre Cdkn2a-/- Eedfl/fl mice 15 days after the first &#946;-naphthoflavone administration (n=5).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_5-B</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Quantification (mean &#177; SD) of Goblet cells along the crypt-to-villus axis from the staining shown in A. More than 100 crypts and villi were scored for each condition.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_5-C</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Immunhistochemistry analysis using anti-KI67 antibody of intestinal sections prepared from AhCre Cdkn2a-/- Eed+/+ and AhCre Cdkn2a-/- Eedfl/fl mice 15 days after the first &#946;-naphthoflavone administration.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_5-D</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Radiation-induced intestinal regeneration: AhCre Cdkn2a-/- Eed+/+ and AhCre Cdkn2a-/- Eedfl/fl mice (n=6) were injected with &#946;-naphthoflavone, irradiated with 10 Gy 15 days later, and sacrificed 8 days after irradiation. Sections prepared from the different intestinal tracts were stained with haematoxylin and eosin (first panels) and Alcian Blue (last panels). Sections were also stained for immunohistochemistry analysis (second and third panels) using H3K27me3 and Ki67-specific antibodies.</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_6-A</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Expression analysis by qRT-PCR (mean &#177; SD) of the indicated intestinal epithelial cell markers regulated by the Wnt and Notch signaling pathways that are involved in stem cell homeostasis, regionalization, and Goblet cell differentiation (n=3).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_6-B</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Genomic snapshots of the indicated genomic loci for SUZ12 occupancy and H3K27me3 deposition in intestinal crypts of wild type mice (n=3).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_6-C</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Expression analysis by qRT-PCR (mean &#177; SD) of the Goblet cell markers (Atoh1, Gfi1, Spdef), early secretory precursor cells (Dll1), NOTCH targets (Hes1, Olfm4) and intestinal stem cells (Lgr5, Rnf43) in wild type intestinal crypts purified 38hrs after treatment with the NOTCH inhibitor DBZ. DMSO served as vehicle negative control (n=4).</text>
    </passage>
  </document>
  <document>
    <id>5090213 Figure_6-D</id>
    <infon key="sourcedata_document">2260</infon>
    <infon key="doi">10.15252/embj.201694550</infon>
    <infon key="pmc_id">5090213</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) ChIP analysis of Atoh1 and Gfi1 loci using H3K27me3 specific antibody. The same crypts described in C were used. H3K27me3 levels were normalized on Histone H3 density (percentage of H3 signal). Graphs show mean &#177; SD.</text>
    </passage>
  </document>
</collection>
